Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 16, 2021

SELL
$1.38 - $2.15 $40,986 - $63,855
-29,700 Closed
0 $0
Q4 2020

Feb 04, 2021

BUY
$0.69 - $0.9 $2,622 - $3,420
3,800 Added 14.67%
29,700 $23,000
Q3 2020

Nov 09, 2020

BUY
$0.72 - $1.04 $1,440 - $2,080
2,000 Added 8.37%
25,900 $19,000
Q2 2020

Jul 31, 2020

BUY
$0.63 - $1.1 $441 - $770
700 Added 3.02%
23,900 $24,000
Q4 2018

Feb 08, 2019

BUY
$1.5 - $5.4 $34,800 - $125,280
23,200 New
23,200 $35,000

About ENDRA Life Sciences Inc.


  • Ticker NDRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 63,174,500
  • Market Cap $17.7M
  • Description
  • ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperat...
More about NDRA
Track This Portfolio

Track National Asset Management, Inc. Portfolio

Follow National Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.